"Unnamed: 0","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-5669034","R-HSA-5669034","TNFs bind their physiological receptors","14/169","29/10891",1.72642404932083e-18,7.99334334835543e-16,6.76031311944577e-16,"CD27/CD70/EDA2R/LTA/TNFRSF13B/TNFRSF14/TNFRSF17/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF8/TNFRSF9/TNFSF8",14
"R-HSA-198933","R-HSA-198933","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","23/169","134/10891",5.39134545247385e-18,1.2480964722477e-15,1.05556868858962e-15,"B2M/CD22/CD300A/CD300C/CD300E/CRTAM/HLA-E/ICAM1/ICAM3/LAIR1/LILRB1/LILRB4/NCR3LG1/NECTIN2/NPDC1/OSCAR/SIGLEC1/SIGLEC10/SIGLEC6/SLAMF6/SLAMF7/TREML2/VCAM1",23
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","14/169","47/10891",5.97529592146627e-15,9.22187337212961e-13,7.79933362380861e-13,"CCL3/CD80/CD86/CSF1/FCER2/ICAM1/IL10/IL10RB/IL12B/IL18/IL6/TNF/TNFRSF1A/TNFRSF1B",14
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","16/169","102/10891",3.30341397581896e-12,3.82370167701044e-10,3.2338684184333e-10,"CD27/CD70/EDA2R/LTA/LTBR/TNF/TNFRSF13B/TNFRSF14/TNFRSF17/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF8/TNFRSF9/TNFSF8",16
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","28/169","473/10891",8.13273250643143e-10,7.5309103009555e-08,6.36921366819472e-08,"BCL2/CCL3/CD80/CD86/CSF1/CSF1R/FCER2/HAVCR2/ICAM1/IFNL1/IFNLR1/IL10/IL10RB/IL12B/IL12RB1/IL15/IL15RA/IL18/IL18BP/IL2RA/IL4R/IL6/LGALS9/SDC1/TNF/TNFRSF1A/TNFRSF1B/VCAM1",28
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","26/169","482/10891",2.4159217748726e-08,1.86428630294335e-06,1.57670684254843e-06,"ADA2/ADAM8/ADGRE5/B2M/B4GALT1/BST2/CANT1/CD14/CD300A/CKAP4/CR1/CTSZ/GM2A/GRN/LAIR1/LRG1/NHLRC3/NPC2/OSCAR/PIGR/PLAUR/PSAP/PTPRC/RNASET2/SIRPB1/TNFRSF1B",26
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","11/169","108/10891",8.52186709700687e-07,5.6366063798774e-05,4.7671196392279e-05,"BCL2/FCER2/ICAM1/IL10/IL12B/IL18/IL4R/IL6/TNF/TNFRSF1B/VCAM1",11
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","6/169","24/10891",1.36380427150783e-06,7.89301722135157e-05,6.67546301316991e-05,"CSF1/CSF1R/IFNL1/IFNLR1/IL10RB/SDC1",6
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","17/169","300/10891",4.02573991164516e-06,0.00020710195323241,0.00017515499966456,"ADAM12/ADAM8/ADAM9/AGRN/BGN/COL18A1/COL4A1/COL6A3/DDR1/ICAM1/ICAM3/LTBP2/MMP12/PDGFB/SDC1/SDC4/VCAM1",17
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","7/169","78/10891",0.00020026484419812,0.00795130037025788,0.0067247555706171,"AREG/CD28/CD80/CD86/EGFR/HBEGF/PDGFB",7
"R-HSA-3560783","R-HSA-3560783","Defective B4GALT7 causes EDS, progeroid type","4/169","20/10891",0.00022325465402451,0.00795130037025788,0.0067247555706171,"AGRN/BGN/SDC1/SDC4",4
"R-HSA-3560801","R-HSA-3560801","Defective B3GAT3 causes JDSSDHD","4/169","20/10891",0.00022325465402451,0.00795130037025788,0.0067247555706171,"AGRN/BGN/SDC1/SDC4",4
"R-HSA-4420332","R-HSA-4420332","Defective B3GALT6 causes EDSP2 and SEMDJL1","4/169","20/10891",0.00022325465402451,0.00795130037025788,0.0067247555706171,"AGRN/BGN/SDC1/SDC4",4
"R-HSA-3000171","R-HSA-3000171","Non-integrin membrane-ECM interactions","6/169","59/10891",0.00029143318029154,0.00963811160535612,0.00815136414048534,"AGRN/COL4A1/DDR1/PDGFB/SDC1/SDC4",6
"R-HSA-216083","R-HSA-216083","Integrin cell surface interactions","7/169","85/10891",0.00034169652369659,0.0105470326981014,0.00892007767123731,"AGRN/COL18A1/COL4A1/COL6A3/ICAM1/ICAM3/VCAM1",7
"R-HSA-3560782","R-HSA-3560782","Diseases associated with glycosaminoglycan metabolism","5/169","41/10891",0.00040437587888734,0.0117016269953026,0.00989656756224297,"AGRN/B4GALT1/BGN/SDC1/SDC4",5
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","4/169","24/10891",0.00046650083053666,0.0127052873257926,0.0107454061275318,"AREG/BCL2/EGFR/HBEGF",4
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","7/169","92/10891",0.00055392435448912,0.013754957367471,0.0116331570778657,"B2M/GBP1/HLA-E/ICAM1/IFI30/IFNGR1/VCAM1",7
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","5/169","44/10891",0.00056445829369751,0.013754957367471,0.0116331570778657,"HAVCR2/IL15/IL15RA/IL2RA/LGALS9",5
"R-HSA-1971475","R-HSA-1971475","A tetrasaccharide linker sequence is required for GAG synthesis","4/169","26/10891",0.00064065845535902,0.0148312432415614,0.0125434181786082,"AGRN/BGN/SDC1/SDC4",4
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","6/169","69/10891",0.00068249119632863,0.0150473059000076,0.0127261516307896,"CD274/CD28/CD80/CD86/PDCD1/TNFRSF14",6
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","3/169","12/10891",0.00072849619672817,0.0153315335947793,0.0129665351762144,"CD28/CD80/CD86",3
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","3/169","13/10891",0.00093628486446075,0.0188478214019707,0.0159404105070663,"AREG/EGFR/HBEGF",3
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","5/169","51/10891",0.00111888129917835,0.0194808221797497,0.0164757663996064,"EFNA1/EFNA4/EPHA2/EPHB4/EPHB6",5
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","7/169","104/10891",0.00115023307033174,0.0194808221797497,0.0164757663996064,"AREG/CD28/CD80/CD86/EGFR/HBEGF/PDGFB",7
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","3/169","14/10891",0.00117810587696111,0.0194808221797497,0.0164757663996064,"AREG/EGFR/HBEGF",3
"R-HSA-3656237","R-HSA-3656237","Defective EXT2 causes exostoses 2","3/169","14/10891",0.00117810587696111,0.0194808221797497,0.0164757663996064,"AGRN/SDC1/SDC4",3
"R-HSA-3656253","R-HSA-3656253","Defective EXT1 causes exostoses 1, TRPS2 and CHDS","3/169","14/10891",0.00117810587696111,0.0194808221797497,0.0164757663996064,"AGRN/SDC1/SDC4",3
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","7/169","106/10891",0.00128590442020418,0.0205301291915356,0.0173632103199983,"AREG/CD28/CD80/CD86/EGFR/HBEGF/PDGFB",7
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","7/169","113/10891",0.00186193006842593,0.0287357873893735,0.0243030872089279,"AREG/CD28/CD80/CD86/EGFR/HBEGF/PDGFB",7
"R-HSA-140534","R-HSA-140534","Caspase activation via Death Receptors in the presence of ligand","3/169","17/10891",0.00212684830754777,0.0302878119837164,0.0256157009388257,"CD14/TNFRSF10A/TNFRSF10B",3
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","3/169","17/10891",0.00212684830754777,0.0302878119837164,0.0256157009388257,"AREG/EGFR/HBEGF",3
"R-HSA-380108","R-HSA-380108","Chemokine receptors bind chemokines","5/169","59/10891",0.0021587425387962,0.0302878119837164,0.0256157009388257,"CCL3/CX3CL1/CXCL13/CXCL9/XCL1",5
"R-HSA-416700","R-HSA-416700","Other semaphorin interactions","3/169","19/10891",0.00296255258220948,0.0391903384446568,0.0331449491904339,"CD72/PTPRC/SEMA7A",3
"R-HSA-9694614","R-HSA-9694614","Attachment and Entry","3/169","19/10891",0.00296255258220948,0.0391903384446568,0.0331449491904339,"AGRN/SDC1/SDC4",3
"R-HSA-1442490","R-HSA-1442490","Collagen degradation","5/169","64/10891",0.00308988133694656,0.0397393071946183,0.0336092355948574,"ADAM9/COL18A1/COL4A1/COL6A3/MMP12",5
"R-HSA-419037","R-HSA-419037","NCAM1 interactions","4/169","42/10891",0.00395656875137347,0.0495105765374573,0.0418732169419895,"AGRN/COL4A1/COL6A3/GFRA1",4
